A concentrated form of prothrombin complex appears to rapidly and permanently reverse the effects of the novel anticoagulant rivaroxaban, a factor Xa inhibitor. But according to results of a small ...
RARITAN, N.J., July 2, 2013 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today results of an open label, single-center, parallel group study showing that a type of ...
Eerenberg ES, Kamphuisen PW, Sijpkens MK, Meijers JC, Buller HR, Levi M. Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate: A Randomized, Placebo-Controlled, Crossover Study in ...
XARELTO (rivaroxaban) 20mg tablets Results of a study conducted by Janssen show that prothrombin complex concentrates can reverse the blood thinning effects of Xarelto (rivaroxaban) in healthy ...
Data Presented at International Society on Thrombosis and Haemostasis (ISTH) 2015 Congress SAN FRANCISCO, Portola Pharmaceuticals today announced results of a study demonstrating that andexanet alfa ...
September 15, 2011 (Amsterdam, the Netherlands) — Results of a small study published online September 6, 2011 in Circulation show that prothrombin complex concentrate (PCC) appears to be an effective ...
Please provide your email address to receive an email when new articles are posted on . Assessment and treatment of a bleeding episode in patients on oral anticoagulants are essential for the proper ...
While internal bleeding may be uncommon as a result of taking blood thinners such as Xarelto® (rivaroxaban) and Eliquis® (apixaban), the normal coagulation tests physicians use to check for the side ...
Rivaroxaban, apixaban and dabigatran are now commonly used as alternatives to vitamin K antagonist therapy (e.g., warfarin) for patients with atrial fibrillation, and for the treatment and prevention ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback